Developer raises $36M, will help fund late-stage Parkinson’s clinical trial

Remepy has raised $36 million in financing, which the company will use in part to fund a late-stage clinical trial testing Hybridopa, its novel treatment strategy for Parkinson’s disease that combines medication with a mobile application. With these funds in hand, the New York-based Remepy expects to launch a Phase 3 trial later this year, […] The post Developer raises $36M, will help fund…